144 related articles for article (PubMed ID: 26134020)
21. Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin.
Ninomiya H; Kawashima Y; Nagasawa T
Br J Haematol; 2000 Jun; 109(4):875-81. PubMed ID: 10929045
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of pre-treatment PNH clone among the patients with aplastic anemia: a meta-analysis.
Li J; Li X; Cai L; Peng X; Yao M; Li S; Zhang G
Hematology; 2023 Dec; 28(1):2204617. PubMed ID: 37191286
[TBL] [Abstract][Full Text] [Related]
23. Glycosylphosphatidyl-inositol (GPI)-linked protein deficiency on the platelets of patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria: two distinct patterns correlating with expression on neutrophils.
Jin JY; Tooze JA; Marsh JC; Gordon-Smith EC
Br J Haematol; 1997 Mar; 96(3):493-6. PubMed ID: 9054654
[TBL] [Abstract][Full Text] [Related]
24. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation.
Rinder CS; Rinder HM; Smith MJ; Tracey JB; Fitch J; Li L; Rollins SA; Smith BR
J Thorac Cardiovasc Surg; 1999 Sep; 118(3):460-6. PubMed ID: 10469960
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.
Dixon RH; Rosse WF
J Clin Invest; 1977 Feb; 59(2):360-8. PubMed ID: 833281
[TBL] [Abstract][Full Text] [Related]
26. Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.
Pakdeesuwan K; Muangsup W; Pratya YU; Issaragrisil S; Wanachiwanawin W
Int J Hematol; 2001 Jan; 73(1):64-70. PubMed ID: 11372757
[TBL] [Abstract][Full Text] [Related]
27. Analysis of platelets by flow cytometry in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).
Araten DJ; Boxer D; Zamechek L; Sherman E; Nardi M
Blood Cells Mol Dis; 2020 Feb; 80():102372. PubMed ID: 31710879
[TBL] [Abstract][Full Text] [Related]
28. Clinical roundtable monograph: Paroxysmal nocturnal hemoglobinuria: a case-based discussion.
Szer J; Hill A; Weitz IC
Clin Adv Hematol Oncol; 2012 Nov; 10(11 Suppl 21):1-16. PubMed ID: 23271156
[TBL] [Abstract][Full Text] [Related]
29. [Evolution of paroxysmal nocturnal hemoglobinuria clone during an hemolytic crisis in a patient with aplastic anemia. Flow cytometry study].
Canalejo K; Galassi N; Riera N; Bengió R; Aixalá M
Medicina (B Aires); 2001; 61(5 Pt 1):581-4. PubMed ID: 11721326
[TBL] [Abstract][Full Text] [Related]
30. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotyping of Paroxysmal Nocturnal Hemoglobinuria (PNH).
Illingworth AJ; Marinov I; Sutherland DR
Methods Mol Biol; 2019; 2032():323-354. PubMed ID: 31522427
[TBL] [Abstract][Full Text] [Related]
33. [Detection of CD59(-) blood cells in patients with aplastic anemia].
Lü Z; Zhang Z; Li D
Zhonghua Xue Ye Xue Za Zhi; 1997 Oct; 18(10):521-4. PubMed ID: 15625826
[TBL] [Abstract][Full Text] [Related]
34. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
35. Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria.
Ruiz-Delgado GJ; Vázquez-Garza E; Méndez-Ramírez N; Gómez-Almaguer D
Hematology; 2009 Feb; 14(1):33-7. PubMed ID: 19154662
[TBL] [Abstract][Full Text] [Related]
36. Analysis of abnormal clones by the fluorescent aerolysin method in paroxysmal nocturnal haemoglobinuria and other marrow disorders.
Agarwal R; Chapple P; Brown M; Szer J; Juneja S
Int J Lab Hematol; 2015 Feb; 37(1):14-21. PubMed ID: 24702736
[TBL] [Abstract][Full Text] [Related]
37. [The variation and clinical significance of paroxysmal nocturnal hemoglobinuria clone in patients with aplastic anemia before and after immunosuppressive therapy].
Sun YX; Zhu MQ; He GS; Wang XL; Fang BZ; Lu C; Liu ZZ; Wu Q; Yang Y; Wu DP; Sun AN
Zhonghua Nei Ke Za Zhi; 2013 Jul; 52(7):585-9. PubMed ID: 24267002
[TBL] [Abstract][Full Text] [Related]
38. [Studies on the expression of complement regulatory proteins in three kinds of stem cell defect anemias and its clinical implications].
Xu C; Zhang T; Zhao R
Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):511-4. PubMed ID: 11721394
[TBL] [Abstract][Full Text] [Related]
39. Aplastic anaemia and paroxysmal nocturnal haemoglobinuria: a study of the GPI-anchored proteins on human platelets.
Vu T; Griscelli-Bennaceur A; Gluckman E; Sigaux F; Carosella ED; Menier C; Scrobohaci ML; Socié G
Br J Haematol; 1996 Jun; 93(3):586-9. PubMed ID: 8652377
[TBL] [Abstract][Full Text] [Related]
40. [Paroxysmal nocturnal hemoglobinuria (PNH) deficiency of major complement-regulatory membrane proteins on erythrocytes].
Ninomiya H; Kobayashi T; Abe T
Rinsho Ketsueki; 1991 Jun; 32(6):612-7. PubMed ID: 1716325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
